Yisaipu Completed Phase 4 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03589833
Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA